Study of malignancy grading of breastcancer based on binding of a lectin helix pomatia agglutinin (HPA)
Study of malignancy grading of breastcancer based on binding of a lectin helix pomatia agglutinin (HPA)
批准号:
01570726
负责人:
RYO Toshio
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1991
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Binding of HPA and DBA to breast cancer tissues was studied histochemically, and their relationships with the prognosis, various clinicopathological factors, grade of nuclear atypism, hormone receptor levels, and nuclear DNA content were evaluated in 164 cases of primary breast cancer.1. Formalin-fixed, paraffin-embedded sections were stained for HPA and DBA. Only the cell membrane of the normal lactiferous duct epithelial cells and the cell membrane and the cytoplasm or the cytoplasm alone of breast cancer cells were stained. HPA was positive in 62.2%, and DBA in 34.8%.2. Concerning the relationship of HPA binding with clinicopathological factors, the HPA positivity rate was significantly higher in tumors 2.1 cm or more and 5.0 cm or less in diameter and those 5.1 or more in diameter than in those 2 cm or less in diameter. It was significantly higher in n(+) cases than in n(-) cases. According to the Tnm classification, the HPA positivity rate was significantly lower in stage I than i … More n stages II, III, or IV. Concerning the histological type, the HPA positivity rate was significantly higher in solid-tubular carcinoma and scirrhous carcinoma than in papillotubular carcinoma. No relationship was observed between the state of menopause and HPA binding.3. HPA binding was not related to the grade of nuclear atypism or hormone receptor levels, but it was significantly related to nuclear DNA content.4. As for the prognosis, the cumulative disease-free survival rate and the cumulative survival rate were both poorer in HPA-positive cases than in HPA-negative cases. In addition, they were both significantly lower in HPA-positive than HPA-negative cases among those positive for ER, those postmenopause, and those in stage I. The cumulative disease-free survival rate was significantly lower in HPA-positive than HPA-negative cases among those having tumors 2 cm or less in diameter and those premenopause.5. Concerning the relationship of DBA binding with various clinicopathological factors, it was not related with the tumor size, histological type, or menopausal state, but it was significantly higher in n(+) cases than in n(-) cases. According to the Tnm classification, it was significantly lower in stage I than in stage II, III, or IV.6. Concerning the prognosis, the cumulative disease-free survival rate and the cumulative survival rate were both significantly poorer in DBA-positive than DBA-negative cases. In addition they were both significantly poorer in DBA-positive than negative among those positive for ER and those postmenopause.In non-diploid type the cumulative disease-free survival rate was significantly lower in DBA-positive than DBA-negative patients.From these findings, simultaneous evaluation of HPA and DBA binding of breast cancer tissues with the grade of nuclear atypism, nuclear DNA content, and hormone receptor levels is considered to be useful for analysis of biological characteristics of individual cases and to provide important clinical information. Less
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
田口忠宏: "乳癌悪性度の研究ーBromodeoxyuridine(BrdV)labeling Indexと核DNA量、ホルモンレセプタ-、核異型度との関連ー" 大阪医科大学雑誌. 47. 161-173 (1988)
Tadahiro Taguchi:“乳腺癌恶性肿瘤的研究 - 溴脱氧尿苷 (BrdV) 标记指数、核 DNA 含量、激素受体和核异型性等级之间的关系” 大阪医科大学杂志 47. 161-173 (1988)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
田口忠宏: "核DNA量およびBromodeoxyuridine Labeling Index(BrdV LI)よりみた乳癌悪性度の検討" 乳癌の臨床. 3. 418-420 (1988)
Tadahiro Taguchi:“基于核 DNA 含量和溴脱氧尿苷标记指数 (BrdV LI) 的乳腺癌恶性肿瘤检查”乳腺癌临床。 3. 418-420 (1988)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
海外基金